Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets pull back as investors prepare for Fed meeting

Tue, 17th Dec 2013 11:24

- US inflation in focus ahead of Fed meeting- German sentiment rises; UK inflation eases- S&P downgrades RSA, Fitch lowers outlook- Cable & Wireless Comms gains on bid speculationtechMARK 2,690.49 +0.16%FTSE 100 6,499.13 -0.35%FTSE 250 15,419.43 +0.23%Markets across Europe were trading in the red on Tuesday morning after a strong showing the day before as investors adopted a cautious approach ahead of the Federal Reserve meeting."Yesterday's rally led many to believe that tapering had either been fully priced in or that investors did not believe the Fed would act at this month's meeting. The response seen in US futures and European indices during the morning session would suggest otherwise," said Market Analyst Craig Erlam from Alpari.This FTSE 100 jumped by 1.3% on Monday, as bargain hunters stepped in to buy on the dips after four straight days of losses which saw the index hit its lowest level since mid-October."Today we're seeing more risk aversion from investors, which isn't overly surprising given that the FOMC will announce tomorrow whether it will scale back its asset purchases or not. Investors appear split on this at the moment, with some pointing to the significant improvement in the data and others warning about the low levels of inflation," Erlam said.As such, investors will be looking closely at November's US consumer price index (CPI) due out later on which is expected to show that inflation picked up to an annualised rate of 1.3% in November, up from 1% the previous month. The core figure, which excludes volatile things such as food and energy, is expected to be unchanged at 1.7%Investors have had plenty of economic data to digest today on this side of the Pond, including a German sentiment survey which smashed forecasts by rising to its highest level since April 2006. Meanwhile, the rate of UK CPI inflation unexpectedly fell to 2.1% last month, edging close to the Bank of England's 2% target.RSA gains despite downgrades; C&W up on bid rumoursRSA Insurance was making gains this morning but continues to trade well below levels seen last week after Friday's profit warning and resignation of its Chief Executive. Subsequently, S&P downgraded its credit rating on the stock on Monday to 'A-' with a 'Developing Outlook', having already downgraded last week, while Fitch cut its outlook to 'Rating Watch Negative'.Telecoms group Cable & Wireless Communications was continuing to rise on speculation that it could be a takeover target of US giant AT&T. The stock rose by 4% yesterday.Temporary power and temperature control group Aggreko was among the heaviest fallers, retreating after a stellar rise the day before as it said that full-year results would be slightly ahead of expectations.Barclays fell after calling for the US courts to block energy regulators from collecting $488m of fines for electricity trading market manipulation. Pharmaceuticals group GlaxoSmithKline declined early on after Deutsche Bank downgraded the stock to 'hold'.Consumer electricals group Dixons declined despite beating forecasts with its first underlying profit in six years during if first half. However, the company did warn that the second half would be tougher.AIM-listed iodine producer Iofina was a big mover this morning, plummeting by nearly a quarter after a profit warning. The company said that underlying earnings this year are likely to be similar to 2012 after expected 2013 shipments from its chemical division were delayed into 2014.FTSE 100 - RisersRSA Insurance Group (RSA) 91.30p +1.33%Sage Group (SGE) 379.40p +1.17%Aberdeen Asset Management (ADN) 458.20p +1.13%Rio Tinto (RIO) 3,251.00p +1.01%Sports Direct International (SPD) 709.00p +0.93%International Consolidated Airlines Group SA (CDI) (IAG) 385.40p +0.89%Persimmon (PSN) 1,154.00p +0.87%TUI Travel (TT.) 393.30p +0.85%United Utilities Group (UU.) 668.50p +0.83%Johnson Matthey (JMAT) 3,217.00p +0.66%FTSE 100 - FallersAdmiral Group (ADM) 1,229.00p -2.54%Petrofac Ltd. (PFC) 1,126.00p -2.34%Aggreko (AGK) 1,611.00p -2.07%Burberry Group (BRBY) 1,445.00p -1.70%Vedanta Resources (VED) 785.00p -1.51%BP (BP.) 466.30p -1.46%Fresnillo (FRES) 718.50p -1.37%Hargreaves Lansdown (HL.) 1,281.00p -1.31%CRH (CRH) 1,468.00p -1.28%Amec (AMEC) 1,046.00p -1.23%FTSE 250 - RisersPerform Group (PER) 250.00p +5.93%Fidessa Group (FDSA) 2,377.00p +3.89%Redrow (RDW) 297.20p +3.48%Synthomer (SYNT) 239.20p +3.28%IP Group (IPO) 169.00p +3.05%CSR (CSR) 614.50p +2.76%Cable & Wireless Communications (CWC) 50.25p +2.55%Inchcape (INCH) 592.00p +2.51%Savills (SVS) 646.00p +2.38%St. Modwen Properties (SMP) 368.50p +2.36%FTSE 250 - FallersAlent (ALNT) 337.20p -3.05%esure Group (ESUR) 239.90p -2.87%UBM (UBM) 632.00p -2.77%Dixons Retail (DXNS) 49.99p -2.55%Debenhams (DEB) 83.85p -2.33%AL Noor Hospitals Group (ANH) 901.50p -2.01%Ladbrokes (LAD) 167.20p -1.88%Informa (INF) 525.50p -1.78%Kenmare Resources (KMR) 19.66p -1.70%Xaar (XAR) 1,096.00p -1.62%BC
More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.